Project
I6T-MC-AMAX
Ongoing - recruitment active · 2022 until 2024
Eckhold Annika, Krieger-Grübel Claudia, Brand Stephan, König Marius
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2022
End Date
2024
Financing
Industry
Study Design
Open Label
Brief description/objective
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate
the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn's Disease